1018 EXPOSURE-VIRAL RESPONSE ANALYSES OF THE NON-NUCLEOSIDE POLYMERASE INHIBITOR ABT-333, FOLLOWING MONOTHERAPY AND ABT-333 PLUS PEGYLATED INTERFERON AND RIBAVIRIN THERAPY
Mensing, S, Menon, R, Klein, C, Diderichsen, P, Kaefer, A, Noertersheuser, P, Awni, W
Published in Journal of hepatology (2010)
Published in Journal of hepatology (2010)
Get full text
Journal Article
189P Pharmacokinetics (PK) of sacituzumab govitecan (SG) in patients (Pts) with metastatic triple-negative breast cancer (mTNBC) and other solid tumors
Sathe, A.G., Singh, I., Singh, P., Diderichsen, P., Wang, X., Chang, P., Phan, S-C., Girish, S., Othman, A.A.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
Population pharmacokinetic (PK) analysis of ABT-869 in solid tumors and acute myelogenous leukemia (AML) patients
Gupta, N., Diderichsen, P. M., Steinberg, J., Ricker, J. L., Humerickhouse, R., Awni, W., Pradhan, R.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
Ng, J, Klein, CE, Diderichsen, P, Da Silva, BA, Bernstein, B, Awni, WM, Chui, YL
Published in Journal of the International AIDS Society (10.11.2008)
Published in Journal of the International AIDS Society (10.11.2008)
Get full text
Journal Article
THU0123 Dose Selection of GLPG0634, a Selective JAK1 Inhibitor, for Rheumatoid Arthritis Phase 2B Studies: PK/PD and Exposure-DAS28 Modeling Approach
Namour, F., Tasset, C., van't Klooster, G., Diderichsen, P.M., Cox, E.
Published in Annals of the rheumatic diseases (01.06.2014)
Published in Annals of the rheumatic diseases (01.06.2014)
Get full text
Journal Article